Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Lavendamycin is a bacterial metabolite that has been found in S. lavendulae and has antimicrobial and anticancer activities.1,2 It is active against various bacteria, including S. pneumoniae, S. aureus, E. coli, P. mirabilis, and P. vulgaris (MICs = 0.13-1 µg/ml), and various fungi, including T. rubrum, T. mentagrophytes, and M. canis (MICs = 0.5 µg/ml for all).1 Lavendamycin is cytotoxic to P388 murine leukemia, MKN45 gastric carcinoma, and WiDr colon adenocarcinoma cells (IC50s = 0.06, 0.1, 0.09 µg/ml, respectively).2 In vivo, lavendamycin (0.4-6.4 mg/kg) increases median survival time in a P388 murine leukemia model.1
WARNING This product is not for human or veterinary use.
1. Isolation of lavendamycin, a new antibiotic from Streptomyces lavendulae. J. Antibiot. (Tokyo) 35(3), 259-265 (1982).
2. Novel cytocidal compounds, oxopropalines from Streptomyces sp. G324 producing lavendamycin. I. Taxonomy of the producing organism, fermentation, isolation and biological activities. J. Antibiot. (Tokyo) 46(11), 1672-1677 (1993).